1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Glucocorticoids Toxicity: new trials by email Literature Review of Glucocorticoids Toxicity trials Research Report on Glucocorticoids Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects 101-PGC-005 - Glucocorticoids Toxicity, COVID-19 | Phase 1 | Unknown | 101 Therapeutics | 6 | 2022-10-29 | 2022-12-14 |
| Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids Prednisone - Glucocorticoids Toxicity, Glucose Intolerance | Phase 1 | Completed | Vanderbilt University Medical Center | 25 | 2017-02-15 | 2020-06-04 |
COVID-19 (1) · Communicable Diseases (1) · Glucose Intolerance (1) · Virus Diseases (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Infections (1) · Lung Diseases (1) · Metabolic Diseases (1) · Nidovirales Infections (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1)
Drugs, Generic (1) · Prednisone (1)
101 Therapeutics (1) · Vanderbilt University Medical Center (1)
India (1) · United States (1)
Vivian K Kawai (1)
K23GM117395 (1)